Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin C
- 1 September 2005
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 39 (9) , 1566-1569
- https://doi.org/10.1345/aph.1e634
Abstract
OBJECTIVE: To describe a case of severe accidental cyanide poisoning following a single ingestion of amygdalin with therapeutic intent. CASE SUMMARY: A 68-year-old patient with cancer presented to the emergency department shortly after her first dose (3 g) of amygdalin with a reduced Glasgow Coma Score, seizures, and severe lactic acidosis requiring intubation and ventilation. The patient also ingested 4800 mg of vitamin C per day. She responded rapidly to hydroxocobalamin treatment. The adverse drug reaction was rated probable on the Naranjo probability scale. DISCUSSION: Amygdalin and laetrile (a synthetic form of amygdalin) are commonly used as complementary or alternative medicine (CAM) for the treatment of cancer. Vitamin C is known to increase the in vitro conversion of amygdalin to cyanide and reduce body stores of cysteine, which is used to detoxify cyanide. Amygdalin has been used for decades by patients with cancer who are seeking alternative therapies, and severe reactions have not been reported with this dose. An interaction with vitamin C is a plausible explanation for this life-threatening response. CONCLUSIONS: This case highlights the fact that CAMs can produce life-threatening toxicity. This case also adds a further note of caution, namely, the potential for serious interactions between CAMs, particularly where there is no tradition of concomitant use.Keywords
This publication has 10 references indexed in Scilit:
- Value of lactic acidosis in the assessment of the severity of acute cyanide poisoningCritical Care Medicine, 2002
- Herb-drug interactionsPublished by Elsevier ,2000
- Trends in Alternative Medicine Use in the United States, 1990-1997JAMA, 1998
- Unproven methods of cancer management. LaetrileCA: A Cancer Journal for Clinicians, 1991
- High-dose ascorbic acid decreases detoxification of cyanide derived from amygdalin (laetrile): studies in guinea pigsCanadian Journal of Physiology and Pharmacology, 1983
- A Clinical Trial of Amygdalin (Laetrile) in the Treatment of Human CancerNew England Journal of Medicine, 1982
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- Conjoint use of laetrile and megadoses of ascorbic acid in cancer treatment: Possible side effectsMedical Hypotheses, 1979
- Laetrile: the cult of cyanide Promoting poison for profitThe American Journal of Clinical Nutrition, 1979